Alliancebernstein L.P. Increases Stake in McKesson Corporation $MCK

Alliancebernstein L.P. increased its stake in McKesson Corporation (NYSE:MCK) by 5.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,394,699 shares of the company’s stock after purchasing an additional 126,684 shares during the period. McKesson accounts for about 0.6% of Alliancebernstein L.P.’s portfolio, making the stock its 24th largest position. Alliancebernstein L.P. owned about 1.94% of McKesson worth $1,850,001,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the stock. GGM Financials LLC purchased a new stake in shares of McKesson during the third quarter valued at $25,000. State of Wyoming purchased a new position in McKesson in the 2nd quarter worth $29,000. Hopwood Financial Services Inc. purchased a new position in McKesson in the 3rd quarter worth $31,000. Abound Wealth Management lifted its position in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after acquiring an additional 24 shares during the period. Finally, Delos Wealth Advisors LLC acquired a new stake in McKesson during the 2nd quarter worth about $35,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Activity at McKesson

In other news, Director Maria Martinez sold 349 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the sale, the director owned 301 shares of the company’s stock, valued at $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last three months. Company insiders own 0.08% of the company’s stock.

McKesson Trading Down 0.3%

Shares of MCK stock opened at $941.51 on Friday. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00. The business’s 50 day moving average is $893.90 and its two-hundred day moving average is $825.35. The company has a market capitalization of $115.32 billion, a P/E ratio of 27.08, a P/E/G ratio of 1.51 and a beta of 0.38.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business’s revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts predict that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Wells Fargo & Company raised their price objective on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. TD Cowen increased their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Robert W. Baird set a $968.00 price target on shares of McKesson in a research report on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. Finally, Weiss Ratings downgraded shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.